메뉴 건너뛰기




Volumn 66, Issue 11, 2014, Pages 3122-3128

Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFLUORESCEIN; GAMMA INTERFERON; GLYCOPROTEIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

EID: 84920052630     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38804     Document Type: Article
Times cited : (54)

References (33)
  • 3
    • 77956195583 scopus 로고    scopus 로고
    • A literature review regarding the management of varicella-zoster virus
    • Bond D, Mooney J,. A literature review regarding the management of varicella-zoster virus. Musculoskeletal Care 2010; 8: 118-22.
    • (2010) Musculoskeletal Care , vol.8 , pp. 118-122
    • Bond, D.1    Mooney, J.2
  • 4
    • 78249267932 scopus 로고    scopus 로고
    • The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: A prospective study
    • Drolet M, Brisson M, Schmader KE, Levin MJ, Johnson R, Oxman MN, et al., The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ 2010; 182: 1731-6.
    • (2010) CMAJ , vol.182 , pp. 1731-1736
    • Drolet, M.1    Brisson, M.2    Schmader, K.E.3    Levin, M.J.4    Johnson, R.5    Oxman, M.N.6
  • 5
    • 84862803493 scopus 로고    scopus 로고
    • Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: A 6-month prospective study
    • Drolet M, Levin MJ, Schmader KE, Johnson R, Oxman MN, Patrick D, et al., Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: a 6-month prospective study. Vaccine 2012; 30: 2047-50.
    • (2012) Vaccine , vol.30 , pp. 2047-2050
    • Drolet, M.1    Levin, M.J.2    Schmader, K.E.3    Johnson, R.4    Oxman, M.N.5    Patrick, D.6
  • 7
    • 35848954757 scopus 로고    scopus 로고
    • A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction
    • Yawn BP, Saddier P, Wollan PC, St. Sauver JL, Kurland MJ, Sy LS,. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007; 82: 1341-9.
    • (2007) Mayo Clin Proc , vol.82 , pp. 1341-1349
    • Yawn, B.P.1    Saddier, P.2    Wollan, P.C.3    St. Sauver, J.L.4    Kurland, M.J.5    Sy, L.S.6
  • 8
    • 79951553465 scopus 로고    scopus 로고
    • EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
    • Van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M, et al., EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2011; 70: 414-22.
    • (2011) Ann Rheum Dis , vol.70 , pp. 414-422
    • Van Assen, S.1    Agmon-Levin, N.2    Elkayam, O.3    Cervera, R.4    Doran, M.F.5    Dougados, M.6
  • 10
    • 56349169958 scopus 로고    scopus 로고
    • Exploring the complex relationships between infections and autoimmunity
    • Doria A, Zampieri S, Sarzi-Puttini P,. Exploring the complex relationships between infections and autoimmunity. Autoimmun Rev 2008; 8: 89-91.
    • (2008) Autoimmun Rev , vol.8 , pp. 89-91
    • Doria, A.1    Zampieri, S.2    Sarzi-Puttini, P.3
  • 12
    • 80052180671 scopus 로고    scopus 로고
    • Risk of herpes zoster in patients with systemic lupus erythematosus: A three-year follow-up study using a nationwide population-based cohort
    • Chen HH, Chen YM, Chen TJ, Lan JL, Lin CH, Chen DY,. Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort. Clinics (Sao Paulo) 2011; 66: 1177-82.
    • (2011) Clinics (Sao Paulo) , vol.66 , pp. 1177-1182
    • Chen, H.H.1    Chen, Y.M.2    Chen, T.J.3    Lan, J.L.4    Lin, C.H.5    Chen, D.Y.6
  • 13
    • 34047185285 scopus 로고    scopus 로고
    • Varicella-zoster vaccine for the prevention of herpes zoster
    • Kimberlin DW, Whitley RJ,. Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med 2007; 356: 1338-43.
    • (2007) N Engl J Med , vol.356 , pp. 1338-1343
    • Kimberlin, D.W.1    Whitley, R.J.2
  • 14
    • 0026777352 scopus 로고
    • Derivation of the SLEDAI: A disease activity index for lupus patients
    • the Committee on Prognosis Studies in SLE.
    • Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-40.
    • (1992) Arthritis Rheum , vol.35 , pp. 630-640
    • Bombardier, C.1    Gladman, D.D.2    Urowitz, M.B.3    Caron, D.4    Chang, C.H.5
  • 15
    • 84870283373 scopus 로고    scopus 로고
    • Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus
    • Barbosa CM, Terreri MT, Rosario PO, de Moraes-Pinto MI, Silva CA, Hilario MO,. Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus. Clin Exp Rheumatol 2012; 30: 791-8.
    • (2012) Clin Exp Rheumatol , vol.30 , pp. 791-798
    • Barbosa, C.M.1    Terreri, M.T.2    Rosario, P.O.3    De Moraes-Pinto, M.I.4    Silva, C.A.5    Hilario, M.O.6
  • 16
    • 44849103815 scopus 로고    scopus 로고
    • Prevention of herpes zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    • the Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC).
    • Harpaz R, Ortega-Sanchez IR, Seward JF, and the Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008; 57: 1-30.
    • (2008) MMWR Recomm Rep , vol.57 , pp. 1-30
    • Harpaz, R.1    Ortega-Sanchez, I.R.2    Seward, J.F.3
  • 17
    • 80054810870 scopus 로고    scopus 로고
    • The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: A longitudinal observational study
    • Zhang J, Delzell E, Xie F, Baddley JW, Spettell C, McMahan RM, et al., The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study. Arthritis Res Ther 2011; 13: R174.
    • (2011) Arthritis Res Ther , vol.13 , pp. R174
    • Zhang, J.1    Delzell, E.2    Xie, F.3    Baddley, J.W.4    Spettell, C.5    McMahan, R.M.6
  • 18
    • 84863515640 scopus 로고    scopus 로고
    • Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases
    • Zhang J, Xie F, Delzell E, Chen L, Winthrop KL, Lewis JD, et al., Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA 2012; 308: 43-9.
    • (2012) JAMA , vol.308 , pp. 43-49
    • Zhang, J.1    Xie, F.2    Delzell, E.3    Chen, L.4    Winthrop, K.L.5    Lewis, J.D.6
  • 19
    • 84880926800 scopus 로고    scopus 로고
    • The case for Zostavax vaccination in systemic lupus erythematosus
    • Cogman AR, Chakravarty EF,. The case for Zostavax vaccination in systemic lupus erythematosus. Vaccine 2013; 31: 3640-3.
    • (2013) Vaccine , vol.31 , pp. 3640-3643
    • Cogman, A.R.1    Chakravarty, E.F.2
  • 20
    • 84859832981 scopus 로고    scopus 로고
    • 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
    • Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al., 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012; 64: 625-39.
    • (2012) Arthritis Care Res (Hoboken) , vol.64 , pp. 625-639
    • Singh, J.A.1    Furst, D.E.2    Bharat, A.3    Curtis, J.R.4    Kavanaugh, A.F.5    Kremer, J.M.6
  • 22
    • 0025183423 scopus 로고
    • The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis
    • Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al., The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101-7.
    • (1990) Arthritis Rheum , vol.33 , pp. 1101-1107
    • Leavitt, R.Y.1    Fauci, A.S.2    Bloch, D.A.3    Michel, B.A.4    Hunder, G.G.5    Arend, W.P.6
  • 23
    • 0019460853 scopus 로고
    • Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and primary Sjögren's syndrome
    • Fauci AS, Moutsopoulos HM,. Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and primary Sjögren's syndrome. Arthritis Rheum 1981; 24: 577-83.
    • (1981) Arthritis Rheum , vol.24 , pp. 577-583
    • Fauci, A.S.1    Moutsopoulos, H.M.2
  • 24
    • 0018887198 scopus 로고
    • Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus
    • Blaese RM, Grayson J, Steinberg AD,. Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus. Am J Med 1980; 69: 345-50.
    • (1980) Am J Med , vol.69 , pp. 345-350
    • Blaese, R.M.1    Grayson, J.2    Steinberg, A.D.3
  • 25
    • 0025277014 scopus 로고
    • High incidence of herpes zoster in patients with systemic lupus erythematosus: An immunological analysis
    • Nagasawa K, Yamauchi Y, Tada Y, Kusaba T, Niho Y, Yoshikawa H,. High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis. Ann Rheum Dis 1990; 49: 630-3.
    • (1990) Ann Rheum Dis , vol.49 , pp. 630-633
    • Nagasawa, K.1    Yamauchi, Y.2    Tada, Y.3    Kusaba, T.4    Niho, Y.5    Yoshikawa, H.6
  • 26
    • 0015335159 scopus 로고
    • Virus antibody levels in systemic lupus erythematosus
    • Hurd ER, Dowdle W, Casey H, Ziff M,. Virus antibody levels in systemic lupus erythematosus. Arthritis Rheum 1972; 15: 267-74.
    • (1972) Arthritis Rheum , vol.15 , pp. 267-274
    • Hurd, E.R.1    Dowdle, W.2    Casey, H.3    Ziff, M.4
  • 27
    • 84864924195 scopus 로고    scopus 로고
    • Epstein-Barr virus and systemic lupus erythematosus
    • Draborg AH, Duus K, Houen G,. Epstein-Barr virus and systemic lupus erythematosus. Clin Dev Immunol 2012; 2012: 370516.
    • (2012) Clin Dev Immunol , vol.2012 , pp. 370516
    • Draborg, A.H.1    Duus, K.2    Houen, G.3
  • 28
    • 43249130506 scopus 로고    scopus 로고
    • Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts
    • Cohrs RJ, Mehta SK, Schmid DS, Gilden DH, Pierson DL,. Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts. J Med Virol 2008; 80: 1116-22.
    • (2008) J Med Virol , vol.80 , pp. 1116-1122
    • Cohrs, R.J.1    Mehta, S.K.2    Schmid, D.S.3    Gilden, D.H.4    Pierson, D.L.5
  • 31
    • 84877654913 scopus 로고    scopus 로고
    • Herpes zoster infections in SLE in a university hospital in Saudi Arabia: Risk factors and outcomes
    • Sayeeda A, Al Arfaj H, Khalil N, Al-Arfaj AS,. Herpes zoster infections in SLE in a university hospital in Saudi Arabia: risk factors and outcomes. Autoimmune Dis 2010; 2010: 174891.
    • (2010) Autoimmune Dis , vol.2010 , pp. 174891
    • Sayeeda, A.1    Al Arfaj, H.2    Khalil, N.3    Al-Arfaj, A.S.4
  • 33
    • 29244433723 scopus 로고    scopus 로고
    • Herpes zoster in immunocompromised patients: Incidence, timing, and risk factors
    • Wung PK, Holbrook JT, Hoffman GS, Tibbs AK, Specks U, Min YI, et al., Herpes zoster in immunocompromised patients: incidence, timing, and risk factors. Am J Med 2005; 118: 1416.
    • (2005) Am J Med , vol.118 , pp. 1416
    • Wung, P.K.1    Holbrook, J.T.2    Hoffman, G.S.3    Tibbs, A.K.4    Specks, U.5    Min, Y.I.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.